Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating activities:    
Consolidated net income (loss) $ 435.6 $ (403.6)
Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 295.2 248.8
Stock-based compensation expense 43.9 40.6
Deferred income taxes 78.0 (81.7)
Gain on fair market value adjustment of equity investments (162.8) 0.0
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (76.1) (49.9)
Other assets, current and long-term 29.6 32.6
Current and long term liabilities, excluding debt 5.6 296.3
Cash provided by operating activities 649.0 83.1
Investing activities:    
Capital expenditures (309.5) (305.7)
Acquisitions, net of cash acquired (61.4) (234.8)
Investment in unconsolidated affiliates, net (10.0) (25.0)
Cash used in investing activities (380.9) (565.5)
Financing activities:    
Net short-term borrowings 0.3 367.0
Payments on long-term debt (125.0) (50.0)
Borrowings on long-term debt 1,123.3 250.0
Dividends paid to Equifax shareholders (142.1) (141.4)
Dividends paid to noncontrolling interests (2.6) (4.8)
Proceeds from exercise of stock options and employee stock purchase plan 29.9 15.3
Payment of taxes related to settlement of equity awards 0.0 (9.7)
Purchase of redeemable noncontrolling interests (9.0) 0.0
Debt issuance costs (9.8) 0.0
Other 0.3 0.0
Cash provided by financing activities 865.3 426.4
Effect of foreign currency exchange rates on cash and cash equivalents 0.9 (0.1)
Increase (decrease) in cash and cash equivalents 1,134.3 (56.1)
Cash and cash equivalents, beginning of period 401.3 223.6
Cash and cash equivalents, end of period $ 1,535.6 $ 167.5